The biological complexity of gene expression makes simulation of gene expression data difficult. We propose a spike-in simulation that adds a single simulated gene to the data set of interest. Features of this spike-in gene may be manipulated to observe how often the spiked-in gene appears in the list of differentially expressed genes. This approach provides insight into the data analysis method, the observed data, and the manner in which the method and data interact without relying on indefensible assumptions regarding gene coexpression.
INTRODUCTION
We propose an approach to simulate the behavior of a single gene embedded in the data set of interest. This approach is analogous to the spike-in approach used to validate expression measurements on an array: biological samples are spiked with known concentrations of a gene to evaluate microarray platform performance and to validate algorithms and methods involved in analysis and preprocessing steps (Shippy and others, 2006; Held and others, 2003) . Spike-in genes have been used to validate methods of filtration, background adjustment, scanning, channel adjustment, and normalization (Hill and others, 2001; Rydén and others, 2006) . Simulation of a single gene preserves the interdependence between genes while allowing manipulation of features (magnitude of effect, time effect, and variance) of that single gene.
One of the most important properties of a data analysis method is the power to detect a differentially expressed gene, but because of the complexity of these methods, the statistical properties rarely have theoretical solutions. In such a case, a simulation study approximates the power by repeatedly sampling from a known probability model. A simulated spike-in gene added to the observed data can be processed and the power approximated by tallying the fraction of simulated samples identifying the spike-in gene as statistically significant. Understanding the power of the data analysis method provides insight into the list of significant genes from a particular experiment. In addition, this approach allows assessment of * To whom correspondence should be addressed. 
SIMULATION
To evaluate the chosen analysis as applied to the observed data, we propose creation of a simulated data set by adding a single simulated gene to the current data set. By manipulating the characteristics of the simulated gene (significance, time effect, and magnitude of differential expression), the sensitivity and power of the proposed method as applied to this data set may be explored.
The algorithm we propose includes the following steps for adding a simulated gene:
1. Determine patterns of interest in the data. These patterns may be found by examining expression patterns in dominant clusters or they may be chosen by the researcher based on previous studies. 2. Generate the expression profile of a single gene across all time points and/or experimental conditions. Append this gene to the existing data set. 3. Analyze the outcome of changing features of the simulated gene. Possible features include the mean vector, the variance, and the degree of correlation as well as the effect of changing the difference between the control and treated arrays.
We present the skeleton of an example from a time course experiment comparing treatment and placebo with 46 observations on each gene (Storey and others, 2005) . Details of this example are available in the supplemental technical report of the supplementary material available at Biostatistics online. To identify genes differentially expressed between the treatment and placebo groups, the null model is fit under the assumption of no differential expression over time; the data are treated as if they represent a single group and a natural cubic spline identifies the best fit over time. The extended model divides the data into the treated and placebo groups and uses a natural cubic spline over time for each group. An F-type statistic is constructed for the ith gene by calculating the relative difference in sums of squared errors between the null and alternative models.
To select the mean vector for generating the simulated gene expression levels, we consider several options guided by the dominant gene expression patterns in the observed data set: averaging across placebo arrays; averaging across nonsignificant genes on the placebo arrays; averaging across significant genes, separately for placebo and treated arrays; and averaging across genes from a common pattern in a hierarchical cluster. For each of these mean vectors, we investigate the effect of correlation, variance, and attenuation of the difference between the control and treated arrays.
For each parameter combination, we separately simulate 1000 genes, append one of these simulated genes to the original data, and count the number of data sets in which the simulated gene is among the top 100 most significant genes. For each mean vector, as correlation across time increases, the spikedin gene is more frequently found in the top 100 most significant genes. As variance increases, significance decreases-with large variance, the simulated gene is almost never ranked in the top 100 genes.
Figure 1(A) displays the mean vectors used to address the effect of attenuation of the difference between the control and treated arrays. These mean vectors have the same shape; however, they differ in the magnitude of the effect. Figure 1(B) confirms that as the difference between the control and treated vectors decreases, the gene is less frequently identified as significant. The proportion of simulated genes ranked in the top 100 drops as the effect attenuates. 
CONCLUSIONS
This spike-in simulation approach provides insight into the data analysis method, the observed data, and the manner in which the method and data interact. The numerical data produced by microarray experiments are relative to the details of the experiment. As a surrogate of the quantity of RNA transcripts, gene expression measurements do not represent an empirical quantity within the cell; they provide only a comparative level of expression relative to other genes. The interpretation of these artificial units is dependent on the type of array being used, how the arrays were prepared, and the other arrays in the sample. The end result of a microarray analysis is a list of genes deemed significant by the method used; however, this information rarely encompasses everything of interest to the researcher. What types of genes are being called significant? What patterns are detected by this method? At what point does a gene fall on the line between significant and nonsignificant? These questions can all be answered by this simulation study.
The spike-in approach, used to validate levels on an array, provides the inspiration for the technique used in this simulation. Spiked genes-genes artificially added to but not naturally found in the sampleare added in known quantities, thereby providing a reference for the experimental results. Similarly, this simulation-based approach adds a single gene with known features to an existing data set. By observing the simulated gene, the researcher can have a better idea of what types of genes the method is finding to be significant and to which gene features the method is most sensitive. Using the steps outlined, one can analyze the consequences of using any analysis method on any gene expression data.
SUPPLEMENTARY MATERIAL
Supplementary material is available at http://biostatistics.oxfordjournals.org.
